B. Matuszewska

Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy--interactions between the active pharmaceutical ingredient and its counterion.

Hong Wang, T. Hwang, Chia-Yi Yang, 2003, Journal of pharmaceutical and biomedical analysis.

In vitro study of intestinal absorption and metabolism of 8-L-arginine vasopressin and its analogues

G. Liversidge, P. Smith, B. Matuszewska, 1988 .

Comparative bioavailability of L-683,453, a 5α-reductase inhibitor, from a self-emulsifying drug delivery system in Beagle dogs

D. Storey, B. Matuszewska, L. Hettrick, 1996 .

Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent.

D. Storey, S. Ruddy, D. Ostovic, 1999, International journal of pharmaceutics.

Formulation Design of Acidic Fibroblast Growth Factor

C. Russell Middaugh, David B. Volkin, D. Volkin, 1993, Pharmaceutical Research.

Acidic Fibroblast Growth Factor: Evaluation of Topical Formulations in a Diabetic Mouse Wound Healing Model

C. Hoe, D. Fisher, K. Soper, 2004, Pharmaceutical Research.